Pharmacological approaches to antibody-mediated rejection-Are we getting closer?

Jean Kwun; Stuart Knechtle

doi:10.1111/ajt.16061

Pharmacological approaches to antibody-mediated rejection-Are we getting closer?

Am J Transplant. 2020 Oct;20(10):2637-2638. doi: 10.1111/ajt.16061. Epub 2020 Aug 15.

Authors

Jean Kwun¹, Stuart Knechtle¹

Affiliation

¹ Duke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.

PMID: 32419361
DOI: 10.1111/ajt.16061

No abstract available

Keywords: alloantibody; animal models: nonhuman primate; editorial/personal viewpoint; immunosuppression/immune modulation; kidney transplantation/nephrology; rejection: antibody-mediated (ABMR).

Publication types

Editorial
Comment

MeSH terms

Abatacept
Animals
Antibody Formation
Bortezomib
Graft Rejection / drug therapy
Humans
Kidney Transplantation*
Mice
Tissue Donors

Substances

Bortezomib
Abatacept